Protara Therapeutics Inc. (TARA)
undefined
undefined%
At close: undefined
5.99
4.54%
After-hours Dec 13, 2024, 07:49 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14
Revenue - - - - - - - - - 2.95M
Cost of Revenue 341.00K 247.00K 1.17M 196.00K 16.00K 115.00K 148.00K 123.00K 57.00K -
Gross Profit -341.00K -247.00K -1.17M -196.00K -16.00K -115.00K -148.00K -123.00K -57.00K 2.95M
Operating Income -43.61M -67.06M -47.49M -34.44M -15.25M -26.08M -30.36M -28.70M -20.87M -7.58M
Interest Income 2.73M 1.11M 237.00K 466.00K - - - - - -
Pretax Income -40.42M -65.95M -47.25M -33.98M -14.99M -25.44M -29.96M -28.53M -21.38M -3.34M
Net Income -40.42M -64.81M -47.13M -33.51M -14.73M -25.44M -29.96M -28.53M -21.38M -3.34M
Selling & General & Admin 18.62M 20.74M 26.40M 22.46M 8.82M 10.57M 8.53M 9.71M 8.43M 4.10M
Research & Development 24.99M 16.81M 21.09M 11.98M 6.44M 15.51M 21.69M 18.87M 12.38M 6.43M
Other Expenses - 29.52M - - - 207.00K - - - -
Operating Expenses 43.61M 37.55M 47.49M 34.44M 15.25M 26.08M 30.21M 28.58M 20.81M 10.53M
Interest Expense - 1.14M 1.74M 34.00K - - 259.00K 193.00K 144.00K 857.00K
Selling & Marketing Expenses - - - - - - 8.42M -123.00K -57.00K -
Cost & Expenses 43.61M 37.55M 47.49M 34.44M 15.25M 26.08M 30.36M 28.70M 20.87M 10.53M
Income Tax - -1.14M -117.00K -466.00K -262.00K 5.35M 657.00K 372.00K -363.00K 5.09M
Shares Outstanding (Basic) 11.33M 11.26M 11.23M 7.23M 64.44K 2.56M 431.86K 414.04K 411.60K 76.61K
Shares Outstanding (Diluted) 11.33M 11.26M 11.23M 7.23M 64.44K 2.56M 431.86K 414.04K 411.60K 76.61K
EPS (Basic) -3.57 -5.76 -4.2 -4.63 -228.6 -9.93 -69.38 -68.9 -51.94 -43.62
EPS (Diluted) -3.57 -5.76 -4.2 -4.63 -228.6 -9.93 -69.38 -68.9 -51.94 -43.62
EBITDA -43.27M -64.57M -46.09M -33.78M -7.81M -20.61M -29.82M -28.40M -21.32M -2.45M
Depreciation & Amortization 341.00K 247.00K 1.17M 196.00K 16.00K 115.00K 148.00K 123.00K 57.00K 30.00K